SCHEMBL21940851

SCHEMBL21940851

Cn1cc(NC(=O)OC(C)(C)C)cc1C(=O)Nc1ccc(-c2cc(C(=O)N3CCSCC3)n(C)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKDC P78527 1/20 0.41
▸ CD274 Q9NZQ7 1/20 0.41
▸ CYP17A1 P05093 3/20 0.38
▸ PTPN2 P17706 1/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ PTPN6 P29350 1/20 0.37
▸ AR P10275 2/20 0.37
▸ DRD2 P14416 1/20 0.36
▸ PSMB8 P28062 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ LIPE Q05469 1/20 0.35
▸ MAPK14 Q16539 1/20 0.35
▸ NAMPT P43490 2/20 0.35
▸ ACHE P22303 1/20 0.35
▸ BACE1 P56817 1/20 0.35
▸ HDAC3 O15379 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21940850 0.92 AR (0.45) PRKDCCD274CYP17A1PTPN2PTPN1
SCHEMBL18976489 0.92 AR (0.41) PRKDCCD274ARDRD2LMNA
SCHEMBL21941150 0.91 AR (0.44) PRKDCCD274CYP17A1PTPN2PTPN1
SCHEMBL18976230 0.89 PRKDC (0.52) PRKDCCD274CYP17A1PTPN2PTPN1
SCHEMBL20581339 0.87 AR (0.42) ARLMNAPOLBTHRBTDP1
SCHEMBL19739304 0.83 CYP17A1 (0.44) PRKDCCD274CYP17A1PTPN2PTPN1
SCHEMBL18976024 0.83 CYP17A1 (0.46) PRKDCCD274CYP17A1PTPN2PTPN1
SCHEMBL21451881 0.83 CYP17A1 (0.44) PRKDCCD274CYP17A1PTPN1DRD2
SCHEMBL26073595 0.83 CYP17A1 (0.47) PRKDCCD274CYP17A1PTPN2PTPN1
SCHEMBL21451758 0.83 MAP4K4 (0.45) PRKDCCD274CYP17A1ARDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10640507-B2 PBD antibacterial agents KING'S COLLEGE LONDON (GB) 2020-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10640507-B2 PBD antibacterial agents OPRD1, XDH, SBDS PRKDC 4382/4885CD274 659/4885CYP17A1 2680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback